Squarex is developing a topical drug for the PREVENTION of cold sores -- herpes labialis or oral herpes outbreaks -- in persons with frequent cold sores. Completed clinical trials show one topical dose to the arm (not the lip) significantly boosts immune response and significantly prevents outbreaks for 3 months.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):